ICCCのチャート
ICCCの企業情報
| symbol | ICCC |
|---|---|
| 会社名 | ImmuCell Corp. （イミュセル） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: In Vitro_In Vivo Diagnostic Substances |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 イミュセル(ImmuCell Corporation)は乳製品と牛肉産業において動物の健康・生産性に測定可能な経済的影響をもたらす科学的に実証される実用的な製品を生産する企業。同社製品「First Defense」はワクチンと牛乳タンパク質精製技術に基づいて牛の初乳から製造される。標的疾患の牛腸炎（子牛下痢症）は新生子牛に下痢と脱水を引き起こし、しばしば重篤な病気や死亡をもたらす。「First Defense」は大腸菌K99とコロナウイルス（下痢の２つの原因）に感染した子牛を対象とする、米農務省（USDA）の認可を受けた唯一の経口送達の下痢予防製品である。「First Defense」は、新生子牛が必要とするウシ抗体を供給する。「Wipe Out Dairy Wipes」は搾乳の事前に牛の乳頭位置を確認するためのナイシンとあらかじめ湿らせた生分解性ティッシュで構成される。 イミュセルは米国の乳牛用製品メ―カ―。乳牛の健康・生産性の向上につながる製品の開発、買収、製造、販売を手掛ける。乳製品・牛肉市場向けに製品を販売。製品には牛ウィルス性下痢予防の高度免疫牛初乳｢ファ―スト・ディフェンス｣などがある。また、潜在性乳房炎治療用にナイシンを主成分とする｢マスト・アウト｣を開発。本社はメイン州。 immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries. |
| 本社所在地 | 56 Evergreen Drive Portland ME 04103 USA |
| 代表者氏名 | David Scott Tomsche デビットスコットトムシェ |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 207-878-2770 |
| 設立年月日 | 1982年 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 1987年 |
| 従業員数 | － |
| url | www.immucell.com |
| nasdaq_url | https://www.nasdaq.com/symbol/iccc |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -0.22340 |
| 終値（lastsale） | 8.9 |
| 時価総額（marketcap） | 48805179.2 |
| 時価総額 | 時価総額（百万ドル） 45.13108 |
| 売上高 | 売上高（百万ドル） 11.03330 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 51.73548 |
| 当期純利益 | 当期純利益（百万ドル） -1.62449 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 ImmuCell Corporation revenues increased 11% to $5.9M. Net loss totaled $1M vs. income of $366K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Product development expenses increase of 85% to $1.3M (expense) Interest expense increase from $83K to $202K (expense). |
ICCCのテクニカル分析
ICCCのニュース
ImmuCell Corporation (ICCC) Q1 2023 Earnings Call Transcript 2023/05/12 14:00:10 Seeking Alpha
ImmuCell Corporation (NASDAQ:NASDAQ:ICCC) Q1 2023 Earnings Conference Call May 12, 2023 9:00 AM ETCompany ParticipantsJoe Diaz - Lytham Partners, IRMichael Brigham - President and…
2023 ICCC Program Provides Free Training, Education, and Mentorship to Small Business Owners 2023/05/12 12:30:00 Accesswire
NORTHAMPTON, MA / ACCESSWIRE / May 12, 2023 / The Initiative for a Competitive Inner City (ICIC) , with support from its funders, invites small business owners from across the United States and Canada to apply to the 2023 Inner City Capital Connections (ICCC) program - a tuition-free, 40-hour "mini-MBA" program that combines executive education, webinars, and coaching delivered by top-ranking university professors, local experts, and financial institutions. The ICCC program is designed to help small businesses in underserved communities develop strategies that build their capacity for sustainable growth and present opportunities to connect with capital sources to create local jobs. "I am so grateful that this program exists - the focus, generosity, and caliber of everyone contributing is just amazing. It is undoubtedly a must for any entrepreneur to take part if they are invited - I can''t imagine who wouldn''t want to glean great advice from professionals in the field, it certainly gives one a great advantage to know there are people and resources available to be successful," said MJ Atelier founder and 2022 ICCC participant Maria Apelo Cruz.
ImmuCell GAAP EPS of -$0.30, revenue of $2.6M 2023/05/11 20:29:08 Seeking Alpha
ImmuCell press release (NASDAQ:ICCC): Q1 GAAP EPS of -$0.30.Revenue of $2.6M (-56.7% Y/Y).
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023 2023/05/11 20:05:00 GlobeNewswire
PORTLAND, Maine, May 11, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended March 31, 2023.
ImmuCell Corporation (ICCC) Q4 2022 Earnings Call Transcript 2023/02/22 17:50:34 Seeking Alpha
ImmuCell Corporation (NASDAQ:NASDAQ:ICCC) Q4 2022 Earnings Conference Call February 22, 2023 9:00 AM ETCompany ParticipantsJoe Diaz - Lytham Partners, IRMichael Brigham - President and…
ImmuCell announces preliminary 2Q sales of $3.9M 2022/07/07 10:58:57 Seeking Alpha
ImmuCell (ICCC) announces preliminary sales results for Q2 of $3.9M, an decrease of 15% Y/Y.1H sales of $9.9M, an increase of 14% Y/Y.“A material disruption in the supply to us of…
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022 2022/07/07 10:30:00 GlobeNewswire
PORTLAND, Maine, July 07, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales results for the second quarter ended June 30, 2022.
JK L-G inaugurates two projects in Srinagar 2022/06/23 16:58:22 The Siasat Daily
Srinagar: Jammu and Kashmir Lieutenant Governor Manoj Sinha on Thursday inaugurated the Integrated Command and Control Centre (ICCC) under the Srinagar Smart City initiative, besides launching the Srinagar Municipal Corporation’s storm water drainage scheme. Terming ICCC as the nerve centre for all Smart City IT interventions, Sinha said that the Centre will act as a … Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .
PUNE INFRA WATCH: PMC to set up centralise command and control centre for all civic issues in city 2022/05/19 19:20:23 The Indian Express
A team of three civic officers will be led by deputy municipal commissioner Pratibha Patil as nodal officer for setting up the ICCC, he said.
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q1 2022 Results - Earnings Call Transcript 2022/05/13 16:20:15 Seeking Alpha
ImmuCell Corporation (NASDAQ:NASDAQ:ICCC) Q1 2022 Earnings Conference Call May 13, 2022 09:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO…
In brief: Santos submits application for Oil Search merger to ICCC and other business stories 2021/11/17 03:29:24 Business Advantage PNG
Santos and Oil Search merger now in the hands of the ICCC, DataCo reduces wholesale prices by 66 per cent for metro fibre connectivity services, and Treasurer Ling-Stuckey receives report on the Central Bank Act 2000 review. The business news you need to know. The post In brief: Santos submits application for Oil Search merger to ICCC and other business stories appeared first on Business Advantage PNG .
ImmuCell Corp (ICCC) CEO Michael Brigham on Q3 2021 Results - Earnings Call Transcript 2021/11/16 19:22:07 Seeking Alpha
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021 2021/11/15 21:05:00 Intrado Digital Media
Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000) Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000)
Bleichroeder LP Makes New Investment in ImmuCell Co. (NASDAQ:ICCC) 2021/10/31 14:32:46 Transcript Daily
Bleichroeder LP bought a new position in shares of ImmuCell Co. (NASDAQ:ICCC) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 60,607 shares of the biotechnology companys stock, valued at approximately $576,000. Bleichroeder LP owned 0.78% of ImmuCell as of its []